Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Two co-marketed brands extend reach: Extensior (Abbott India, T2D, February 2026 launch) deepens specialist endocrinology distribution
Key Takeaways IGF1 LR3 is a modified analog of IGF1 with a longer halflife, offering sustained activity (2030 hours) and higher potency than native IGF1
Probably not the best idea
Improving these phases is associated with better sleep quality, improved tissue regeneration, higher growth hormone release during sleep, and enhanced memory consolidation
Read that background separately from this news update: the regulatory status described here is tied to the July 23 committee result and can change again when FDA acts
US$ 23.29
US$ 24.89
US$ 26.22
US$ 24.36
